About Us

Supriya Lifescience Limited headquartered in Mumbai, India is a public listed generic pharmaceutical company established in 1987 dedicated to developing, commercializing APIs & FDFs to treat patients with various diseases and infections. The API facility located at Lote, Maharashtra, India is multiple times USFDA, EDQM/EUGMP approved, and Health Canada approved.

Read More Watch Video

Area of Focus

API

FDF

CDMO
40+

Products

86+

Countries

1500+

Customers

22%

& above CAGR since 2019

400+

Employee Strength

We have a global footprint that extends across 86 countries

APIs

FDF

Awards

Latest News

01 November 2024

Supriya Lifescience reports 19% revenue increase in Q2 FY25

Read More

30 October 2024

Supriya Lifescience Second Quarter 2025 Earnings: EPS: ₹5.71 (vs ₹2.97 in 2Q 2024)

Read More

29 October 2024

Supriya Lifescience: A Promising Smallcap Pharma Stock with Strong Financials and Positive Market Performance

Read More

29 October 2024

Supriya Lifescience Q2 Revenue Up 19%, Driven By Anaesthetic Segment

Read More

29 October 2024

SUPRIYA LIFESCIENCE Gains 4%; BSE HEALTHCARE Index Down 1.0%

Read More

29 October 2024

Supriya Lifescience Ltd. Reports Strong Q2 FY25 Growth With 19% Yoy Revenue Increase.

Read More

29 October 2024

Supriya Lifescience's Stock Sees 7.4% Increase, Outperforms Market and Sector

Read More

29 October 2024

Supriya Lifesci Standalone September 2024 Net Sales at Rs 166.10 crore, up 18.56% Y-o-Y

Read More

25 October 2024

From Dreams to Reality: The Remarkable Entrepreneurial Journey of Dr. Satish Wagh in the Pharmaceutical Industry

Read More

Several awards for excellence and outstanding performance.

Established in the year 1987, Supriya Lifescience Ltd. is a global leading manufacturer of Active pharmaceutical Ingredients. Our state-of-the-art facility is certified by USFDA, EDQM, EUGMP, NMPA & Health Canada. Facility is located in Khed, District Ratnagiri and headquartered in Mumbai, India.

Read More
BSE
NSE